This is a Validated Antibody Database (VAD) review about Rhesus mon.. CD44, based on 175 published articles (read how Labome selects the articles), using CD44 antibody in all methods. It is aimed to help Labome visitors find the most suited CD44 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD44 synonym: CD44 antigen; Phagocytic glycoprotein I

BioLegend
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). Aging (Albany NY) (2019) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (Biolegend, IM7) was used in immunocytochemistry on mouse samples (fig 2a). Biol Sex Differ (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4f
BioLegend CD44 antibody (Biolegend, 103031) was used in flow cytometry on mouse samples (fig s4f). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1e
BioLegend CD44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples (fig s1e). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1e
BioLegend CD44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples (fig s1e). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend CD44 antibody (Biolegend, 103057) was used in flow cytometry on mouse samples (fig 2h). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1d
BioLegend CD44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples at 1:200 (fig 1d). elife (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8b
BioLegend CD44 antibody (BioLegend, 103054) was used in flow cytometry on mouse samples (fig s8b). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend CD44 antibody (Biolegend, 103039) was used in flow cytometry on mouse samples (fig 5c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8c). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1f). J Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend CD44 antibody (Biolegend, 103043) was used in flow cytometry on mouse samples (fig 1e). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD44 antibody (Biolegend, 103047) was used in flow cytometry on mouse samples (fig 2b). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s4a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s5d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5d). JCI Insight (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 1c
BioLegend CD44 antibody (Biolegend, 103012) was used in flow cytometry on mouse samples at 1:400 (fig 1c). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend CD44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples (fig 7a). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 5d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 5d). Nat Commun (2018) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, 338802) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). PLoS ONE (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1c). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s19
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s19). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e2e
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig e2e). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3f). EMBO J (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2h). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (BioLegend, 103020) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
  • immunocytochemistry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (Biolegend, 103035) was used in flow cytometry on mouse samples (fig 1b) and in immunocytochemistry on mouse samples (fig 1c). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1h
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1h). Nat Commun (2018) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 3s1b
BioLegend CD44 antibody (BioLegend, 338806) was used in flow cytometry on human samples (fig 3s1b). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • immunoprecipitation; human; loading ...; fig sf1
  • immunocytochemistry; human; 1:250; loading ...; fig sf2
BioLegend CD44 antibody (Biolegend, IM-7) was used in immunoprecipitation on human samples (fig sf1) and in immunocytochemistry on human samples at 1:250 (fig sf2). Oncotarget (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4c). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s1a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig s1a). Nat Commun (2017) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD44 antibody (BioLegend, BJ18) was used in flow cytometry on human samples (fig 2c). Cytokine (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
In order to evaluate mouse models of hepacivirus infection, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s8c). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2k
In order to investigate the role of dopamine in B cell maturation in germinal centres, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2k). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
In order to characterize the regulatory T cells expressing T-bet transcriptional factor, BioLegend CD44 antibody (BioLegend, 103026) was used in flow cytometry on mouse samples (fig 3f). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s3b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s3b). Nat Commun (2017) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD44 antibody (BioLegend, BJ18) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1c
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3a). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4f). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on human samples (fig 2b). Oncogenesis (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to find factors that regulate follicular T helper cell migration and function, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5b). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3c). Nat Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend CD44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to assess the contribution of viral infection to the development of celiac disease, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; cat; loading ...; fig 1e
  • flow cytometry; human; loading ...; fig 1f
In order to compare human and feline adipose-derived mesenchymal stem cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on cat samples (fig 1e) and in flow cytometry on human samples (fig 1f). Stem Cell Res Ther (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6b). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to examine the contribution of T-bet-expressing B cells to autoimmune diseases, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 2b). Stem Cells Dev (2017) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; mouse; 1:100; loading ...; fig 6a
In order to report the expression pattern of Gpr182 during development and adulthood using knockin mice, BioLegend CD44 antibody (BioLegend, 338810) was used in flow cytometry on mouse samples at 1:100 (fig 6a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Mucosal Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Oncotarget (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to report that differentiation and self-renewal arise as opposing outcomes of sibling CD4 positive T cells during challenge with influenza, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig s1c
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, BioLegend CD44 antibody (Biolegend, BJ18) was used in flow cytometry on human samples (fig s1c). Cell Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to investigate strains of Listeria monocytogenes that activate necrosis, apoptosis, or pyroptosis and study the role of CD8 positive T cells in these processes, BioLegend CD44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Infect Immun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 6c
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 6c). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6f
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4
In order to characterize systemic antimicrobial CD4 positive T cell reactivity, BioLegend CD44 antibody (Biolegend, Im7) was used in flow cytometry on mouse samples (fig s4). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; loading ...; fig 5e
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:800 (fig 5e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (BioLegend, 103022) was used . Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3
BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; loading ...; fig 3g
BioLegend CD44 antibody (BioLegend, IM7) was used in immunocytochemistry on human samples (fig 3g). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6d
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig s1). Cell (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2
BioLegend CD44 antibody (Biolegend, 103015) was used in flow cytometry on human samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig S1
In order to study the effect of IL-10 signaling in infectious neurological diseases, BioLegend CD44 antibody (BioLegend, clone IM7) was used in flow cytometry on mouse samples (fig S1). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to probe how neutrophil extracellular traps modulate the rheumatoid arthritis-associated autoimmune response, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Eur J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3d
In order to test if a combination of LYN and Aire defects result in organ-specific autoimmunity, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to demonstrate that lymphotoxin beta receptor directly controls thymic endothelial cells to guide hematopoietic progenitor cell homing, BioLegend CD44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to assess how ABCG1 loss in T cells affects atherosclerosis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 4
BioLegend CD44 antibody (Biolegend, 103015) was used in immunocytochemistry on human samples (fig 4). Biol Open (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 4
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 4). J Virol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 4
BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples at 1:100 (fig 4). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 4f
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 4f). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; loading ...; fig 1a
  • immunohistochemistry; human; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, IM7) was used in immunohistochemistry on mouse samples (fig 1a) and in immunohistochemistry on human samples (fig 1a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
In order to study promotion of host immunity and protection against IL-12/23p40-dependent lung injury during hookworm infection by myeloid-restricted AMPK-alpha1, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). J Immunol (2016) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; mouse; 1:50; loading ...; fig 7f
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., BioLegend CD44 antibody (Biolegend, 338807) was used in flow cytometry on mouse samples at 1:50 (fig 7f). Nat Cell Biol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3e
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3c
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Gastroenterology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1b
BioLegend CD44 antibody (Biolegend, 103029) was used in flow cytometry on human samples (fig 1b). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6s
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6s). J Immunol (2016) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; fig 4
BioLegend CD44 antibody (Biolegend, BJ18) was used in flow cytometry on human samples (fig 4). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend CD44 antibody (Biolegend, 1M7) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2f
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, BioLegend CD44 antibody (BioLegend, 103016) was used in flow cytometry on mouse samples at 1:400 (fig 2f). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Int J Oncol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend CD44 antibody (Biolegend, 103026) was used in flow cytometry on mouse samples (fig 6). Nature (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, 103030) was used . Sci Rep (2015) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; fig 8
In order to identify the source of obesity-induced MCP-1 and identify molecular regulators mediating MCP-1 production, BioLegend CD44 antibody (Biolegend, BJ18) was used in flow cytometry on human samples (fig 8). Mol Metab (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; cat; fig 2
In order to examine the effect of fresh, autologous, adipose-derived mesenchymal stem cells on feline chronic gingivostomatitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on cat samples (fig 2). Stem Cells Transl Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend CD44 antibody (BioLegend, IMF7) was used in flow cytometry on mouse samples (fig 1). Nat Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1d). Arthritis Rheumatol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s7
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s7). elife (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (BioLegend, 103021) was used . Mol Med Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3a). Cancer Res (2015) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; fig 4
In order to determine the differential regulation of the inflammatory phenotype of brain microvascular endothelial cells by pro-inflammatory TNFalpha and IL-1beta, BioLegend CD44 antibody (Biolegend, 338803) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Leukoc Biol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, IM7) was used . Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s6
BioLegend CD44 antibody (Biolegend, 103024) was used in flow cytometry on mouse samples (fig s6). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 1
BioLegend CD44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s2). Brain (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
BioLegend CD44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 3). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, 103012) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to examine the role of interleukin-4 in relation to eomesodermin within CD8+ T cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; human; fig 2
  • flow cytometry; mouse; fig 1
In order to study reprogramming of cells toward a metastatic-like state by p53 psi, a transcriptionally inactive p53 isoform, BioLegend CD44 antibody (Biolegend, IM-7) was used in immunohistochemistry on human samples (fig 2) and in flow cytometry on mouse samples (fig 1). Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate how Fbw7-mediated GATA3 regulation and CDK2-mediated phosphorylation of Cdc4 phosphodegron regulate differentiation of T-cell lineages, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Mol Cell Biol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples . Ann Neurol (2014) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, 103014) was used . PLoS ONE (2014) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human
BioLegend CD44 antibody (BioLegend, 2BJ18) was used in flow cytometry on human samples . Cell Death Dis (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
BioLegend CD44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 4). Vaccine (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:200; loading ...; fig st13
BioLegend CD44 antibody (Biolengend, IM7) was used in immunocytochemistry on human samples at 1:200 (fig st13). Nat Cell Biol (2014) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; 0.5 ug/ml; loading ...; fig st13
BioLegend CD44 antibody (Biolengend, BJ18) was used in flow cytometry on human samples at 0.5 ug/ml (fig st13). Nat Cell Biol (2014) ncbi
rat monoclonal (IM7)
In order to evaluate a coculture system for in vitro colonoid formation, BioLegend CD44 antibody (Biolegend, 103001) was used . Am J Physiol Gastrointest Liver Physiol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend CD44 antibody (BioLegend, 103009) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cell Cycle (2012) ncbi
Abcam
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 5f
  • immunohistochemistry; rat; 1:200; loading ...; fig 9a
In order to develop and characterize a rat model of glioma, Abcam CD44 antibody (Abcam, ab157107) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 5f) and in immunohistochemistry on rat samples at 1:200 (fig 9a). PLoS ONE (2017) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s4g
In order to elucidate novel functions of the senescence-associated secretory in promoting a proregenerative response through the induction of cell plasticity and stemness, Abcam CD44 antibody (Abcam, ab157107) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s4g). Genes Dev (2017) ncbi
rabbit polyclonal
  • flow cytometry; rabbit; fig 1
  • flow cytometry; rat; fig 1
Abcam CD44 antibody (Abcam, ab157107) was used in flow cytometry on rabbit samples (fig 1) and in flow cytometry on rat samples (fig 1). Sci Rep (2016) ncbi
Articles Reviewed
  1. Shikama Y, Kurosawa M, Furukawa M, Ishimaru N, Matsushita K. Involvement of adiponectin in age-related increases in tear production in mice. Aging (Albany NY). 2019;11:8329-8346 pubmed publisher
  2. Noguerol J, Roustan P, N Taye M, Delcombel L, Rolland C, Guiraud L, et al. Sexual dimorphism in PAR2-dependent regulation of primitive colonic cells. Biol Sex Differ. 2019;10:47 pubmed publisher
  3. Benci J, Johnson L, Choa R, Xu Y, Qiu J, Zhou Z, et al. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 2019;178:933-948.e14 pubmed publisher
  4. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  5. Maji B, Gangopadhyay S, Lee M, Shi M, Wu P, Heler R, et al. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9. Cell. 2019;177:1067-1079.e19 pubmed publisher
  6. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  7. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  8. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun. 2019;10:1492 pubmed publisher
  9. Sinclair L, Howden A, Brenes A, Spinelli L, Hukelmann J, Macintyre A, et al. Antigen receptor control of methionine metabolism in T cells. elife. 2019;8: pubmed publisher
  10. Michaels Y, Barnkob M, Barbosa H, Baeumler T, Thompson M, Andre V, et al. Precise tuning of gene expression levels in mammalian cells. Nat Commun. 2019;10:818 pubmed publisher
  11. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  12. Yamamoto T, Lee P, Vodnala S, Gurusamy D, Kishton R, Yu Z, et al. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019;129:1551-1565 pubmed publisher
  13. Faliti C, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A, et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med. 2019;216:317-336 pubmed publisher
  14. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  15. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  16. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  17. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  18. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  19. Gejman R, Chang A, Jones H, DiKun K, Hakimi A, Schietinger A, et al. Rejection of immunogenic tumor clones is limited by clonal fraction. elife. 2018;7: pubmed publisher
  20. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  21. Glal D, Sudhakar J, Lu H, Liu M, Chiang H, Liu Y, et al. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol. 2018;9:2522 pubmed publisher
  22. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  23. Sang A, Danhorn T, Peterson J, Rankin A, O Connor B, Leach S, et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun. 2018;9:3973 pubmed publisher
  24. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  25. Cummings M, Arumanayagam A, Zhao P, Kannanganat S, Stuve O, Karandikar N, et al. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE. 2018;13:e0200752 pubmed publisher
  26. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  27. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed publisher
  28. Nusse Y, Savage A, Marangoni P, Rosendahl Huber A, Landman T, De Sauvage F, et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature. 2018;559:109-113 pubmed publisher
  29. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  30. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  31. Drobek A, Moudra A, Mueller D, Huranová M, Horková V, Pribikova M, et al. Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells. EMBO J. 2018;37: pubmed publisher
  32. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  33. Gounder A, Yokoyama C, Jarjour N, Bricker T, Edelson B, Boon A. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 2018;14:e1007001 pubmed publisher
  34. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  35. Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9:1095 pubmed publisher
  36. Lee C, Zhang H, Singh S, Koo L, Kabat J, Tsang H, et al. C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation. elife. 2018;7: pubmed publisher
  37. Fahl S, Coffey F, Kain L, Zarin P, Dunbrack R, Teyton L, et al. Role of a selecting ligand in shaping the murine γδ-TCR repertoire. Proc Natl Acad Sci U S A. 2018;115:1889-1894 pubmed publisher
  38. Chen X, Nagai Y, Zhu Z, Ruan H, Peehl D, Greene M, et al. A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77. Oncotarget. 2018;9:3631-3640 pubmed publisher
  39. Koh A, Miller E, Buenrostro J, Moskowitz D, Wang J, Greenleaf W, et al. Rapid chromatin repression by Aire provides precise control of immune tolerance. Nat Immunol. 2018;19:162-172 pubmed publisher
  40. Nakashima H, Alayo Q, Penaloza MacMaster P, Freeman G, Kuchroo V, Reardon D, et al. Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells. Sci Rep. 2018;8:208 pubmed publisher
  41. Ernszt D, Banfai K, Kellermayer Z, Pap A, Lord J, Pongracz J, et al. PPARgamma Deficiency Counteracts Thymic Senescence. Front Immunol. 2017;8:1515 pubmed publisher
  42. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  43. Kim M, Yoo S, Kang S, Kwon J, Choi I, Lee C. TNF? and IL-1? in the synovial fluid facilitate mucosal-associated invariant T (MAIT) cell migration. Cytokine. 2017;99:91-98 pubmed publisher
  44. Wang Y, Yun C, Gao B, Xu Y, Zhang Y, Wang Y, et al. The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation. Cell Rep. 2017;20:600-612 pubmed publisher
  45. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  46. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  47. Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421-425 pubmed publisher
  48. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  49. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, et al. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. PLoS ONE. 2017;12:e0178352 pubmed publisher
  50. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  51. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  52. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  53. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  54. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  55. Lu P, Shih C, Qi H. Ephrin B1-mediated repulsion and signaling control germinal center T cell territoriality and function. Science. 2017;356: pubmed publisher
  56. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  57. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  58. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  59. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  60. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  61. Connolly N, Stokum J, Schneider C, Ozawa T, Xu S, Galisteo R, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. PLoS ONE. 2017;12:e0174557 pubmed publisher
  62. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  63. Clark K, Fierro F, Ko E, Walker N, Arzi B, Tepper C, et al. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther. 2017;8:69 pubmed publisher
  64. Bhattacharyya M, Penaloza MacMaster P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology. 2017;151:340-348 pubmed publisher
  65. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  66. Rubtsova K, Rubtsov A, Thurman J, Mennona J, Kappler J, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 2017;127:1392-1404 pubmed publisher
  67. Ritschka B, Storer M, Mas A, Heinzmann F, Ortells M, Morton J, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 2017;31:172-183 pubmed publisher
  68. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed publisher
  69. Kechele D, Blue R, Zwarycz B, Espenschied S, Mah A, Siegel M, et al. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. J Clin Invest. 2017;127:593-607 pubmed publisher
  70. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  71. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed publisher
  72. Nish S, Zens K, Kratchmarov R, Lin W, Adams W, Chen Y, et al. CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med. 2017;214:39-47 pubmed publisher
  73. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  74. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  75. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  76. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  77. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  78. Theisen E, Sauer J. Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. Infect Immun. 2017;85: pubmed publisher
  79. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  80. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  81. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  82. Kwong Chung C, Ronchi F, Geuking M. Detrimental effect of systemic antimicrobial CD4+ T-cell reactivity on gut epithelial integrity. Immunology. 2017;150:221-235 pubmed publisher
  83. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  84. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  85. Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
  86. Liu Z, Tian R, Li Y, Zhang L, Shao H, Yang C, et al. SDF-1?-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia. Sci Rep. 2016;6:34416 pubmed publisher
  87. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  88. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  89. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  90. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  91. Chai Y, Lee E, Gubbe J, Brekke J. 3D Cell Culture in a Self-Assembled Nanofiber Environment. PLoS ONE. 2016;11:e0162853 pubmed publisher
  92. Uhde A, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, et al. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS ONE. 2016;11:e0161883 pubmed publisher
  93. Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46:2542-2554 pubmed publisher
  94. Proekt I, Miller C, Jeanne M, Fasano K, Moon J, Lowell C, et al. LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity. J Clin Invest. 2016;126:3758-3771 pubmed publisher
  95. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  96. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  97. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  98. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed publisher
  99. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  100. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  101. Liu W, Kang S, Huang Z, Wu C, Jin H, Maine C, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901-19 pubmed publisher
  102. Stanly T, Fritzsche M, Banerji S, Garcia E, Bernardino de la Serna J, Jackson D, et al. Critical importance of appropriate fixation conditions for faithful imaging of receptor microclusters. Biol Open. 2016;5:1343-50 pubmed publisher
  103. Di Scala M, Otano I, Gil Farina I, Vanrell L, Hommel M, Olague C, et al. Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice. J Virol. 2016;90:8563-74 pubmed publisher
  104. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  105. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  106. Nasri I, Bonnet D, Zwarycz B, d Aldebert E, Khou S, Mezghani Jarraya R, et al. PAR2-dependent activation of GSK3? regulates the survival of colon stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol. 2016;311:G221-36 pubmed publisher
  107. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  108. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  109. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  110. Nieves W, Hung L, Oniskey T, Boon L, Foretz M, Viollet B, et al. Myeloid-Restricted AMPK?1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection. J Immunol. 2016;196:4632-40 pubmed publisher
  111. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  112. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  113. Rialdi A, Campisi L, Zhao N, Lagda A, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352:aad7993 pubmed publisher
  114. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  115. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  116. Mall C, Sckisel G, Proia D, Mirsoian A, Grossenbacher S, Pai C, et al. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016;5:e1075114 pubmed
  117. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  118. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  119. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  120. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  121. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  122. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  123. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  124. Gradiz R, Silva H, Carvalho L, Botelho M, Mota Pinto A. MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648 pubmed publisher
  125. Pelly V, Kannan Y, Coomes S, Entwistle L, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407-1417 pubmed publisher
  126. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  127. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  128. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  129. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  130. Zhang X, Ma Y, Fu X, Liu Q, Shao Z, Dai L, et al. Runx2-Modified Adipose-Derived Stem Cells Promote Tendon Graft Integration in Anterior Cruciate Ligament Reconstruction. Sci Rep. 2016;6:19073 pubmed publisher
  131. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  132. Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, et al. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol. 2016;48:953-64 pubmed publisher
  133. Lindemans C, Calafiore M, Mertelsmann A, O Connor M, Dudakov J, Jenq R, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528:560-564 pubmed publisher
  134. Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George G, Hong D, et al. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015;5:17533 pubmed publisher
  135. Kaplan J, Marshall M, C McSkimming C, Harmon D, Garmey J, Oldham S, et al. Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue. Mol Metab. 2015;4:779-94 pubmed publisher
  136. Arzi B, Mills Ko E, Verstraete F, Kol A, Walker N, Badgley M, et al. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Transl Med. 2016;5:75-86 pubmed publisher
  137. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  138. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  139. Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias G, et al. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016;68:449-61 pubmed publisher
  140. McCormack R, de Armas L, Shiratsuchi M, Fiorentino D, Olsson M, Lichtenheld M, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. elife. 2015;4: pubmed publisher
  141. Wei T, Zhang N, Guo Z, Chi F, Song Y, Zhu X. Wnt4 signaling is associated with the decrease of proliferation and increase of apoptosis during age-related thymic involution. Mol Med Rep. 2015;12:7568-76 pubmed publisher
  142. Martin Blondel G, Pignolet B, Tietz S, Yshii L, Gebauer C, Périnat T, et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur J Immunol. 2015;45:3302-12 pubmed publisher
  143. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  144. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed publisher
  145. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  146. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  147. Pei B, Zhao M, Miller B, Véla J, Bruinsma M, Virgin H, et al. Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation. J Immunol. 2015;194:5872-84 pubmed publisher
  148. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  149. Lujan E, Zunder E, Ng Y, Goronzy I, Nolan G, Wernig M. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature. 2015;521:352-6 pubmed publisher
  150. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  151. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  152. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  153. Srivastava M, Duan G, Kershaw N, Athanasopoulos V, Yeo J, Ose T, et al. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis. Nat Commun. 2015;6:6253 pubmed publisher
  154. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  155. Cabrera Perez J, Condotta S, James B, Kashem S, Brincks E, Rai D, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194:1609-20 pubmed publisher
  156. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  157. Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398-413 pubmed publisher
  158. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  159. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed publisher
  160. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  161. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed publisher
  162. Carty S, Koretzky G, Jordan M. Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS ONE. 2014;9:e106659 pubmed publisher
  163. Chatterjee S, Thyagarajan K, Kesarwani P, Song J, Soloshchenko M, Fu J, et al. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014;74:6048-59 pubmed publisher
  164. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  165. Senturk S, Yao Z, Camiolo M, Stiles B, Rathod T, Walsh A, et al. p53? is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state. Proc Natl Acad Sci U S A. 2014;111:E3287-96 pubmed publisher
  166. Kitagawa K, Shibata K, Matsumoto A, Matsumoto M, Ohhata T, Nakayama K, et al. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol. 2014;34:2732-44 pubmed
  167. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  168. Sahlberg S, Spiegelberg D, Glimelius B, Stenerlow B, Nestor M. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS ONE. 2014;9:e94621 pubmed publisher
  169. Diessner J, Bruttel V, Stein R, Horn E, Häusler S, Dietl J, et al. Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1). Cell Death Dis. 2014;5:e1149 pubmed publisher
  170. Yan J, Villarreal D, Racine T, Chu J, Walters J, Morrow M, et al. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine. 2014;32:2833-42 pubmed publisher
  171. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  172. Hwang W, Jiang J, Yang S, Huang T, Lan H, Teng H, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268-80 pubmed publisher
  173. Hirokawa Y, Yip K, Tan C, Burgess A. Colonic myofibroblast cell line stimulates colonoid formation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G547-56 pubmed publisher
  174. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  175. Bonuccelli G, Castello Cros R, Capozza F, Martinez Outschoorn U, Lin Z, Tsirigos A, et al. The milk protein ?-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle. 2012;11:3972-82 pubmed publisher